Claris Lifesciences receives MHRA approval for new plant

Capital Market

Last Updated : Aug 21 2014 | 11:15 AM IST

To help enhance capacities to cater European markets

Claris Lifesciences announced that it has received MHRA approval for its newly commissioned plant (plant 2). This will help in enhancing capacities to grow in the regulated markets, especially the European Union.

Powered by Capital Market - Live News

More From This Section

Machino Plastics announces resignation of nominee director

Machino Plastics announces change in nominee director

Board of White Diamond Industries approves change in directorate

Board of Central Provinces Railways Company approves scheme of arrangment for reduction of capital

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 21 2014 | 10:03 AM IST

Explore News

Stock Market LIVE Updates Stocks to Watch Today Shadowfax Technologies IPO Cipla Q3 Results Q3 Result Today Why Market is Falling Delhi AQI Today Budget Week Market Outlook Budget 2026 Stock Market Holiday